The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2016 | The role of imaging techniques in defining response in multiple myeloma
Evangelos Terpos, MD, PhD, University of Athens, Athens, Greece gives an overview of the session on imaging and disease assessment in multiple myeloma (MM) held at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France. Dr Terpos explains that even though the standard criteria of reponse (complete response, partial response and progressive or stable disease) are defined by the International Myeloma Working Group, there are responses beyond the complete response (CR). He outlines the role of imaging in defining myeloma and complete response as well as the role of minimal residual disease (MRD) and the criteria that can be used to decide which patients need therapy at diagnosis using imaging techniques such as MRI, PET-CT and some novel techniques such as diffusion weighted imaging MRI.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
